EUVIMEDEUVIMED entdecken
Open Access

Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors

Yuyan Jiang, Hongbin Cao, Huaping Deng, Li Guan, Jimpi Langthasa, Deana Rae Crystal Colburg, Stavros Melemenidis, Renee M Cotton, John Aleman, Xiao-Jing Wang, Edward E Graves, Anusha Kalbasi und 3 weitere

Nature Biotechnology · 2025-09 · 43 (9) · 1496-1509

DOI: 10.1038/s41587-024-02448-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nature Biotechnology, online erschienen am 24.10.2024. Verfasst von Yuyan Jiang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Stanford University, Stanford, CA, USA. Hauptthemen laut MEDLINE: Gold, RNA, Small Interfering, Radiosurgery, Neoplasms. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI), NIDCR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoldRNA, Small InterferingRadiosurgeryNeoplasmsHead and Neck NeoplasmsAnimalsMiceHumansCell Line, TumorGalectin 1Metal NanoparticlesNeoplasm MetastasisFemaleRadiation-Sensitizing Agents

Substanzen

GoldRNA, Small InterferingGalectin 1Radiation-Sensitizing Agents

Autor:innen und Institutionen

  • Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
  • Department of Pathology, Stanford University, Stanford, CA, USA.
  • Department of Comparative Medicine, Stanford University, Stanford, CA, USA.
  • Department of Pathology, University of Colorado, Anschutz Medical Campus, Aurora, CO, USA.
  • Department of Pathology and Laboratory Medicine, School of Medicine, University of California, Davis, Sacramento, CA, USA.
  • Veterans Affairs Northern California Health Care System, Mather, CA, USA.

Förderung

  • NCI NIH HHS
  • U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
  • NIDCR NIH HHS
  • BLRD VA
  • U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR)

Zitieren

APA

Jiang, Y., Cao, H., Deng, H., Guan, L., Langthasa, J., Colburg, D. R. C., Melemenidis, S., Cotton, R. M., Aleman, J., Wang, X. J., Graves, E. E., Kalbasi, A., Pu, K., Rao, J., & Le, Q. T. (2025). Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors. Nature Biotechnology, 43(9), 1496-1509. https://doi.org/10.1038/s41587-024-02448-0

Vancouver

Jiang Y, Cao H, Deng H, Guan L, Langthasa J, Colburg DRC, et al. Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors. Nature Biotechnology. 2025;43(9):1496-1509. doi:10.1038/s41587-024-02448-0

BibTeX
@article{Jiang2025,
  author = {Jiang, Yuyan and Cao, Hongbin and Deng, Huaping and Guan, Li and Langthasa, Jimpi and Colburg, Deana Rae Crystal and Melemenidis, Stavros and Cotton, Renee M and Aleman, John and Wang, Xiao-Jing and Graves, Edward E and Kalbasi, Anusha and Pu, Kanyi and Rao, Jianghong and Le, Quynh-Thu},
  title = {Gold-siRNA supraclusters enhance the anti-tumor immune response of stereotactic ablative radiotherapy at primary and metastatic tumors},
  journal = {Nature Biotechnology},
  year = {2025},
  volume = {43},
  number = {9},
  pages = {1496--1509},
  doi = {10.1038/s41587-024-02448-0}
}
Kostenlos starten →